Diversity oriented synthesis of chromene-xanthene hybrids as anti-breast cancer agents.

A diverse library of chromene-xanthene hybrids were synthesized through intramolecular Friedel-Crafts reaction of the arenoxy carbinols. Examples include first incorporation of amino acid tyrosine into xanthene skeletons with polar functionalities. A careful structural evaluation revealed that tyrosine crafted chromene-xanthene hybrids exhibited good activities against breast cancer cell lines MCF-7, MDA-MB-231. The lead compound 16 displays significant cell cycle arrest at G1 phase and induces apoptosis in MDA-MB-231 cells.

Indium triflate catalysed 3-aza-Cope rearrangement of amino acid derived α,ß-unsaturated esters to alkylidene oxindoles.

The first examples of amino acid derived α,ß-unsaturated esters to Z-alkylidene oxindoles via 3-aza-Cope rearrangement using In(OTf)3 are reported.

Synthesis of enantiomerically enriched indolines and tetrahydroisoquinolines from (S)-amino acid-derived chiral carbocations: an easy access to (3S,4R)-demethoxy-3-isopropyl diclofensine.

Enantiomerically enriched indolines and tetrahydroisoquinolines were synthesized within 5 min to 2 h in high yields from easily accessible (S)-amino acid derived chiral carbocations. The diastereoselective Friedel-Crafts reaction is promoted by a Lewis acid (AlCl3) offering trans-diastereoselectivity. The rate of the reaction and diastereoselectivity of the product are significantly influenced by steric hindrance of the amino acids substituents and aryl groups. The methodology can be applied for the synthesis of the enantiomerically enriched bioactive scaffold (3S,4R)-demethoxy-3-isopropyl diclofensine.

Water, an Essential Element for a ZnII -Catalyzed Asymmetric Quinone Diels-Alder Reaction: Multi-Selective Construction of Highly Functionalized cis-Decalins.

A ZnII complex of a C2 -chiral bisamidine-type sp2 N bidentate ligand (LR ) possessing two dioxolane rings at both ends catalyzes a highly efficient quinone asymmetric Diels-Alder reaction (qADA) between o-alkoxy-p-benzoquinones and 1-alkoxy-1,3-butadienes to construct highly functionalized chiral cis-decalins, proceeding in up to a >99:1 enantiomer ratio with a high generality in the presence of H2 O (H2 O:ZnII =4-6:1). In the absence of water, little reaction occurs. The loading amount of the chiral ligand can be minimized to 0.02 mol % with a higher Zn/LR ratio. This first success is ascribed to a supramolecular 3D arrangement of substrates, in which two protons of an "H2 O-ZnII " reactive species make a linear hydrogen bond network with a dioxolane oxygen atom and one-point-binding diene; the ZnII atom captures the electron-accepting two-points-binding quinone fixed on the other dioxolane oxygen atom via an n-π* attractive interaction. The mechanisms has been supported by 1 H NMR study, kinetics, X-ray crystallographic analyses of the related ZnLR complexes, and ligand and substrate structure-reactivity-selectivity relationship.

Thiophene containing trisubstituted methanes [TRSMs] as identified lead against Mycobacterium tuberculosis.

Triarylmethanes (TRAMs) and thiophene containing trisubstituted methanes (TRSMs) have been reported by us, having potential against Mycobacterium tuberculosis and Mycobacterium fortuitum strains, respectively. Further, extension through synthesis and biological evaluation of novel TRSMs resulted into an identified lead 36 (S006-830) [(diisopropyl-(2-{4-[(4-methoxy-phenyl)- thiophen-2-yl-methyl]-phenoxy}-ethyl)-amine)] with MIC: 1.33 mg/L, non-toxic against Vero C-1008 cell line with selectivity index >10, ex vivo efficacy equivalent to first line TB drugs-isoniazid (INH), rifampicin (RFM) and pyrazinamide (PZA) in the mouse and human macrophages, and lung CFU count of 2.2 × 10(7) (approximately 15 fold lesser than untreated mice, 31 × 10(7)) with efficacies comparable to ethambutol (EMB) (1.27 × 10(7)) and PZA (1.9 × 10(7)). Further, S006-830 also showed potent bactericidal activity against multi-drug resistant and single-drug resistant clinical isolates of M. tuberculosis.